Ceriello Antonio, Esposito Katherine, Ihnat Michael, Thorpe Jessica, Giugliano Dario
Warwick Medical School, Clinical Science Research Institute, Clinical Science Building, University Hospital, Walsgrave Campus, Clifford Bridge Road, Coventry, UK.
J Clin Endocrinol Metab. 2009 Aug;94(8):2751-6. doi: 10.1210/jc.2009-0762. Epub 2009 Jun 2.
The objective of the study was to investigate the effect of different periods of hyperglycemia on the reversal of endothelial dysfunction by glucose normalization and antioxidant therapy.
Ten healthy subjects and three subgroups of 10 type 1 diabetic subjects were enrolled as follows: 1) patients within 1 month of diagnosis; 2) patients between 4.5 and 5.2 yr from diagnosis and with glycosylated hemoglobin levels 7% or greater since diagnosis; 3) patients between 4.8 and 5.4 yr from diagnosis and with glycosylated hemoglobin levels greater than 7% since diagnosis. Each patient participated in three experiments: 1) 24-h insulin treatment, achieving a near normalization of glycemia, together with the addition of the antioxidant vitamin C during the last 12 h; 2) 24-h vitamin C treatment with insulin treatment for the last 12 h; and 3) treatment with both vitamin C and insulin for 24 h.
Endothelial function, as measured by flow-mediated vasodilation of the brachial artery and levels of nitrotyrosine, an oxidative stress marker, were normalized by each treatment in subgroups 1 and 2. In the third subgroup, neither glucose normalization nor vitamin C treatment alone was able to normalize endothelial dysfunction or oxidative stress. Combining insulin and vitamin C, however, normalized endothelial dysfunction and nitrotyrosine.
This study suggests that long-lasting hyperglycemia in type 1 diabetic patients induces long-term alterations in endothelial cells, which may contribute to endothelial dysfunction and is interrupted only by both glucose and oxidative stress normalization.
本研究的目的是调查不同时期的高血糖对通过血糖正常化和抗氧化治疗逆转内皮功能障碍的影响。
招募了10名健康受试者和3组各10名1型糖尿病受试者,分组如下:1)诊断后1个月内的患者;2)诊断后4.5至5.2年且自诊断以来糖化血红蛋白水平≥7%的患者;3)诊断后4.8至5.4年且自诊断以来糖化血红蛋白水平大于7%的患者。每位患者参与三项实验:1)24小时胰岛素治疗,使血糖接近正常化,并在最后12小时添加抗氧化剂维生素C;2)24小时维生素C治疗,最后12小时联合胰岛素治疗;3)维生素C和胰岛素联合治疗24小时。
通过肱动脉血流介导的血管舒张和氧化应激标志物硝基酪氨酸水平测量的内皮功能,在第1组和第2组的每种治疗后均恢复正常。在第3组中,单独的血糖正常化或维生素C治疗均无法使内皮功能障碍或氧化应激恢复正常。然而,胰岛素和维生素C联合使用可使内皮功能障碍和硝基酪氨酸恢复正常。
本研究表明,1型糖尿病患者长期高血糖会导致内皮细胞长期改变,这可能导致内皮功能障碍,只有血糖和氧化应激均恢复正常才能中断这种改变。